Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Dowling

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Frontiers in Immunology|July 25, 2022
NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit InflammationEmily J Lelliott, Kelly M Ramsbottom, Mark R Dowling, et al.
Bone Marrow Transplantation|April 23, 2026
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDSMiles Horton, Becky Leung, Ricky Nelles, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2026
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort studyGemma K Reynolds, Mark R Dowling, Safia Belbachir, et al.
Immunity|November 5, 2025
Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival programZhoujie Ding, Mark R Dowling, Adam K Wade-Vallance, et al.
Leukemia & Lymphoma|November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomasDaniel Fasser, Greta Joy, Mark R Dowling, et al.
The Journal of Experimental Medicine|September 14, 2011
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce plateletsEmma C Josefsson, Chloé James, Katya J Henley, et al.
Blood|July 11, 2025
Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomicsRaymond K H Yip, Jeremy Er, Lei Qin, et al.
Blood|February 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphomaMark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S Kittai, David Bond, Ying Huang, et al.
American Journal of Hematology|July 2, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern EraCecelia R Miller, Ying Huang, John N Allan, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Frontiers in Immunology|July 25, 2022
NKG7 Enhances CD8+ T Cell Synapse Efficiency to Limit InflammationEmily J Lelliott, Kelly M Ramsbottom, Mark R Dowling, et al.
Bone Marrow Transplantation|April 23, 2026
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDSMiles Horton, Becky Leung, Ricky Nelles, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 24, 2026
Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort studyGemma K Reynolds, Mark R Dowling, Safia Belbachir, et al.
Immunity|November 5, 2025
Long-lived IgE plasma cells persist in secondary lymphoid tissues using a navitoclax-sensitive survival programZhoujie Ding, Mark R Dowling, Adam K Wade-Vallance, et al.
Leukemia & Lymphoma|November 6, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomasDaniel Fasser, Greta Joy, Mark R Dowling, et al.
The Journal of Experimental Medicine|September 14, 2011
Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce plateletsEmma C Josefsson, Chloé James, Katya J Henley, et al.
Blood|July 11, 2025
Profiling the spatial architecture of multiple myeloma in human bone marrow trephine biopsy specimens with spatial transcriptomicsRaymond K H Yip, Jeremy Er, Lei Qin, et al.
Blood|February 17, 2026
Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphomaMark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2024
Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective StudyAdam S Kittai, David Bond, Ying Huang, et al.
American Journal of Hematology|July 2, 2025
Prognostic Implication of Karyotypic Evaluation in Patients With Richter Transformation in the Modern EraCecelia R Miller, Ying Huang, John N Allan, et al.
Pageof 6